Preview Mode Links will not work in preview mode


Aug 31, 2014

Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute describes how he helps his EGFR lung cancer patients make decisions about next steps in treatment when their cancers grow.

Aug 19, 2014

Dr. Guru Sonpavde highlights the top research news in immunotherapy for kidney cancer from the ASCO 2014 Annual Meeting.

Aug 17, 2014

Biomarkers can give clues to many predictive and prognostic issues, like how a patient may respond to a drug or if a patient's cancer is likely to recur. Dr. Daniel Heng discusses what researchers are learning.

Aug 14, 2014

Dr. Lauren Harshman discusses what combinations of drugs are being studied in kidney cancer patients.

Aug 12, 2014

Cometriq (cabozantinib) is already approved for thyroid cancer and is showing promise for late stage kidney cancer.